Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Rouprêt

Showing results (11-20 of 608) with videos related to

Pageof 61
Sort By:
Presse Medicale (Paris, France : 1983)|July 23, 2003
[Why doesn't France train more surgeons?]Diane Lazard, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|July 15, 2006
[Delegation of medical tasks: an issue in the necessary reorganization of health care in France]Morgan Rouprêt, Guy Vallancien
Bulletin Du Cancer|July 5, 2020
[Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC]Yohann Loriot, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|November 13, 2002
[Concerning residency, will the entropy end?]Laurence Strompf, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|December 22, 2004
[Should French surgery been helped?]Morgan Rouprêt, Yves Pouliquen
Presse Medicale (Paris, France : 1983)|June 21, 2005
[Without delay we should invent urological surgery for tomorrow]Morgan Rouprêt, Christian Coulange
European Urology|February 28, 2017
Re: Long-term Oncological Outcomes of an Active Surveillance Program in Recurrent Low Grade Ta Bladder CancerJuliette Cotte, Morgan Rouprêt
World Journal of Urology|September 28, 2012
Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasmsMorgan Rouprêt, Pierre Colin
Presse Medicale (Paris, France : 1983)|March 19, 2004
[Pleading for a quality medical statistics training]Vincent Huperta, Morgan Rouprêt
Scottish Medical Journal|October 5, 2022
Ureteroscopic biopsy for upper tract urothelial cancers: A valuable double-edged tool in the era of a risk-stratified approachMorgan Rouprêt, Giorgio Calleris
Pageof 61

Showing results (11-20 of 608) with videos related to

Sort By:
Pageof 61
Presse Medicale (Paris, France : 1983)|July 23, 2003
[Why doesn't France train more surgeons?]Diane Lazard, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|July 15, 2006
[Delegation of medical tasks: an issue in the necessary reorganization of health care in France]Morgan Rouprêt, Guy Vallancien
Bulletin Du Cancer|July 5, 2020
[Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC]Yohann Loriot, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|November 13, 2002
[Concerning residency, will the entropy end?]Laurence Strompf, Morgan Rouprêt
Presse Medicale (Paris, France : 1983)|December 22, 2004
[Should French surgery been helped?]Morgan Rouprêt, Yves Pouliquen
Presse Medicale (Paris, France : 1983)|June 21, 2005
[Without delay we should invent urological surgery for tomorrow]Morgan Rouprêt, Christian Coulange
European Urology|February 28, 2017
Re: Long-term Oncological Outcomes of an Active Surveillance Program in Recurrent Low Grade Ta Bladder CancerJuliette Cotte, Morgan Rouprêt
World Journal of Urology|September 28, 2012
Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasmsMorgan Rouprêt, Pierre Colin
Presse Medicale (Paris, France : 1983)|March 19, 2004
[Pleading for a quality medical statistics training]Vincent Huperta, Morgan Rouprêt
Scottish Medical Journal|October 5, 2022
Ureteroscopic biopsy for upper tract urothelial cancers: A valuable double-edged tool in the era of a risk-stratified approachMorgan Rouprêt, Giorgio Calleris
Pageof 61